Evans, C. E., Miners, J. S., Piva, G., Willis, C. L., Heard, D. M., Kidd, E. J., . . . Kehoe, P. G. (2020). ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer’s disease. Acta Neuropathol.

Evans, Charles E., James S. Miners, Giulia Piva, Christine L. Willis, David M. Heard, Emma J. Kidd, Mark A. Good, and Patrick G. Kehoe. "ACE2 Activation Protects against Cognitive Decline and Reduces Amyloid Pathology in the Tg2576 Mouse Model of Alzheimer’s Disease." Acta Neuropathol 2020.

Evans, Charles E., et al. "ACE2 Activation Protects against Cognitive Decline and Reduces Amyloid Pathology in the Tg2576 Mouse Model of Alzheimer’s Disease." Acta Neuropathol 2020.